A new triple antiviral drug combination has shown early promise in treating less severe COVID-19 in phase 2 randomised trial, a study published in The…
The US government’s top infectious disease expert, Anthony Fauci, has backed a randomized, placebo-controlled study of Gilead Sciences Inc.’s antiviral drug, remdesivir, to treat patients…
